ENABLE BIOSCIENCES
Enable Biosciences is a biotech company making ultrasensitive tests for hiv, type 1 diabetes, and many other diseases. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.
ENABLE BIOSCIENCES
Industry:
Biotechnology Life Science
Founded:
2015-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.enablebiosciences.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Enable Biosciences
National Institutes of Health
National Institutes of Health investment in Grant - Enable Biosciences
National Science Foundation
National Science Foundation investment in Grant - Enable Biosciences
National Science Foundation
National Science Foundation investment in Grant - Enable Biosciences
Official Site Inspections
http://www.enablebiosciences.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Enable Biosciences"
Enable Biosciences - Crunchbase Company Profile & Funding
Enable Biosciences may be growing as it has recently received a significant Small Business Innovation Research (SBIR) grant. The company was awarded a $3 million grant for the …See details»
Our Team - Enable Biosciences
Jason Tsai PhD, Co-Founder and Chief Technology Officer. Jason is an inventor of the core ADAP technology and has extensive knowledge of immunology, protein biochemistry and …See details»
Enable Biosciences Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Enable Biosciences Inc. of South San Francisco, CA. Get the latest business insights from Dun & …See details»
Enable Biosciences, Inc. | Intellectual Property & Industry Research ...
Brief Description. Enable Biosciences is an early-stage biotech company creating the next generation of tools for predictive medicine, with diagnostics 10,000x more sensitive than …See details»
Type 1 Testing - Enable Biosciences
Organization size. Message. Submit. Enable Biosciences laboratory tests are intended for clinical use only. These tests were developed and their performance characteristics were determined …See details»
Enable Biosciences - Craft
Enable Biosciences has 5 employees at their 1 location and $3 m in total funding,. See insights on Enable Biosciences including office locations, competitors, revenue, financials, executives, …See details»
Enable Biosciences Inc | www.inknowvation.com
Sep 21, 2022 Enable Biosciences is an early stage firm developing a patent-pending technology platform designed to enable ultra-sensitive antibody detection for research and clinical …See details»
Enable Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Enable Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 9 news, and 16 literature.See details»
Enable Biosciences - LinkedIn
Enable Biosciences is a South San Francisco-based diagnostics company. We develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.See details»
Contact - Enable Biosciences
510 Myrtle Ave Suite 101 South San Francisco CA 94080 [email protected]See details»
Enable Biosciences - Work in biotech
Enable Biosciences is developing innovative diagnostic tools for early disease detection in Type 1 diabetes and celiac disease. Their proprietary technology platform, ADAP (Antibody Detection …See details»
Enable Biosciences - Products, Competitors, Financials, Employees ...
Headquarters Location. 510 Myrtle Avenue Suite 101. South San Francisco, California, 94080, United States. 650-240-3105See details»
Enable Biosciences Profile - highergov.com
Enable Biosciences (UEI D82RA1JMEBA8, CAGE 7FSW3) based in South San Francisco CA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Enable Biosciences - Overview, News & Similar companies
Feb 12, 2024 For more about Enable, visitwww.enablebiosciences.com. For press inquiries, email [email protected]. Research reported in this press release is supported by the …See details»
Enara Bio Strengthens Senior Leadership with Key Executive and …
4 days ago Oxford, United Kingdom – May 01, 2025.Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and …See details»
Laboratory — Enable Biosciences
Enable Biosciences operates out of 3,400 square feet of laboratory and office space in beautiful South San Francisco, “The Birthplace of Biotech.”See details»
Enable Biosciences Appoints Will Robberts as Chief Financial …
Apr 4, 2024 Enable Biosciences Inc. is a leading diagnostic healthcare company based in South San Francisco. With a global presence across 4 continents, Enable is dedicated to advancing …See details»
Enable Biosciences - VentureRadar
Website: http://www.enablebiosciences.com. Develops technology to detect antibodies in bodily fluids, with products designed for autoimmune diabetes, allergies ...See details»
Enara Bio Strengthens Senior Leadership with Key Executive
4 days ago Stacey Davis appointed as Chief Business Officer and Chief Financial Officer. Clive Wood, Ph.D. joins Enara Board as Non-executive Director. Oxford, United Kingdom – May 01, …See details»
Blog — Enable Biosciences
Enable Biosciences is proud to announce we were selected from hundreds of companies as a Finalist in the Breakthrough COVID-19 category for a UCSF Health Award.See details»